* Streamline Health Solutions Inc STRM.OQ STRM.O is expected
to show a rise in quarterly revenue when it reports results on
December 8.
* The Alpharetta Georgia-based company is expected to report a
81.8% increase in revenue to $4.803 million from $2.64 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for Streamline Health
Solutions Inc is for a loss of 4 cents per share. For the same
quarter last year, the company reported a loss of 4 cents per
share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Streamline
Health Solutions Inc is $2.75, about 50.9% above its last
closing price of $1.35.
This summary was machine generated December 3 at 11:05 GMT. All
figures in US dollars unless otherwise stated